Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer

BACKGROUND: The use of neoadjuvant therapy (NAC) for the treatment of potentially resectable pancreatic cancer remains controversial. In this study we sought to evaluate cancer-specific end-points in patients undergoing a NAC vs. a surgery-first (SF) approach with specific emphasis on lymph node met...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Roland, Christina L., Yang, Anthony D., Katz, Matthew H. G., Chatterjee, Deyali, Wang, Huamin, Lin, Heather, Vauthey, Jean N., Pisters, Peter W., Varadhachary, Gauri R., Wolff, Robert A., Crane, Christopher H., Lee, Jeffrey E., Fleming, Jason B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5131370/
https://ncbi.nlm.nih.gov/pubmed/25352267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4192-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados